Sambrana, Rowena T.
HRN: 29-13-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2026
CEFUROXIME 1.5GM (VIAL)
07/10/2026
07/10/2026
IV
1.5gms
LD
UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines